Subscribe to RSS

DOI: 10.1055/s-0045-1810608
Gamma Knife Radiosurgery in Pediatric Patients: Indications and Evolution over Twenty Years of Experience
Authors

Abstract
Objective
This article aims to summarize 22 years of pediatric experience using three generations of the Gamma Knife and show how technological advances in the machine have led to better safety, patient tolerance, and wide application.
Method
A retrospective review of Gamma Knife radiosurgery (GKRS) patients younger than 18 years, treated from 1999 to 2020, was conducted. Data points include primary pathology, age, lesion volume, radiation dose, fixation type, and single session versus hypofractionation. The Gamma Knife models used during this period were the Model 4C, Perfexion, and Icon, and we discuss the evolved planning and treatment delivery options.
Results
Fifty-five patients aged 2.8 to 18 years (49% between 15 and 18 years old) underwent 80 treatments: 55% of patients had tumors, and 45% had AVMs. A rigid frame was used for 49 patients; while six were secured with a thermoplastic mask, five patients had single session, with one having multiple treatments and one hypofractionation. In this group, six sessions were under general anesthesia and six with monitored anesthesia care. They presented mean deviation from the post-stereotactic registration baseline of 0.15 mm. The median dose was 20 Gy (8–28 Gy), and the median lesion volume was 1.066 cc (0.081–34.791 cc). No radiation-induced tumors have been detected in the follow-up so far.
Conclusion
GKRS is a viable modality for pediatric patients needing intracranial radiation. A variety of tumors, as well as AVMs, can be treated. Some level of anesthesia/sedation is required for most patients. The advent of thermoplastic mask fixation has expanded the use of the Gamma Knife to younger patients.
* Current affiliation: Seattle Children's Hospital – Neurosurgery, Seattle, WA, USA.
** Current affiliation: Geisinger Medical Center – Radiation Oncology, Danville, PA, USA.
*** Current affiliation: Geisinger Medical Center – Pediatric Department, Danville, PA, USA.
Publication History
Article published online:
31 July 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Al Saiegh F, Liu H, El Naamani K. et al. Frameless angiography-based Gamma Knife stereotactic radiosurgery for cerebral arteriovenous malformations: a proof-of-concept study. World Neurosurg 2022; 164: e808-e813
- 2 Deora H, Tripathi M, Tewari MK. et al. Role of gamma knife radiosurgery in the management of intracranial gliomas. Neurol India 2020; 68 (02) 290-298
- 3 Marcus KJ, Goumnerova L, Billett AL. et al. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 2005; 61 (02) 374-379
- 4 Ehret F, Kaul D, Budach V, Lohkamp LN. Applications of frameless image-guided robotic stereotactic radiotherapy and radiosurgery in pediatric neuro-oncology: a systematic review. Cancers (Basel) 2022; 14 (04) 1085
- 5 Murphy ES, Sahgal A, Regis J. et al. Pediatric cranial stereotactic radiosurgery: meta-analysis and international stereotactic radiosurgery society practice guidelines. Neuro-oncol 2024;
- 6 Dho YS, Kim YH, Kim JW. et al. Optimal strategy of gamma knife radiosurgery for craniopharyngiomas. J Neurooncol 2018; 140 (01) 135-143
- 7 Graffeo CS, Perry A, Link MJ, Daniels DJ. Pediatric craniopharyngiomas: a primer for the skull base surgeon. J Neurol Surg B Skull Base 2018; 79 (01) 65-80
- 8 Börcek AO, Çeltikçi E, Aksoğan Y, Rousseau MJ. Clinical outcomes of stereotactic radiosurgery for cerebral arteriovenous malformations in pediatric patients: systematic review and meta-analysis. Neurosurgery 2019; 85 (04) E629-E640
- 9 Winkler EA, Lu A, Morshed RA. et al. Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in children. J Neurosurg Pediatr 2020; 26 (01) 82-91
- 10 Ilyas A, Chen CJ, Ding D. et al. Volume-staged versus dose-staged stereotactic radiosurgery outcomes for large brain arteriovenous malformations: a systematic review. J Neurosurg 2018; 128 (01) 154-164
- 11 Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD. An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother Oncol 2002; 63 (03) 347-354
- 12 Larkin CJ, Abecassis ZA, Yerneni K. et al. Volume-staged versus dose-staged stereotactic radiosurgery, with or without embolization, in the treatment of large brain arteriovenous malformations: a systematic review and meta-analysis. J Clin Neurosci 2024; 129: 110883
- 13 Chen CJ, Chivukula S, Ding D. et al. Seizure outcomes following radiosurgery for cerebral arteriovenous malformations. Neurosurg Focus 2014; 37 (03) E17
- 14 Przybylowski CJ, Ding D, Starke RM. et al. Seizure and anticonvulsant outcomes following stereotactic radiosurgery for intracranial arteriovenous malformations. J Neurosurg 2015; 122 (06) 1299-1305
- 15 Begolli E, Winther CH, Miranda MJ, Mol Debes N. The placebo effect in the treatment of children with epilepsy: a systematic review. Seizure 2025; 127: 7-15